Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06507059 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Outcomes of the PLHIV With Suboptimal Viral Suppression to Injectable Long-acting Antiretrovirals

Name: Outcomes of the PLHIV With Suboptimal Viral Suppression to Injectable Long-acting Antiretrovirals — clinical trial record (NCT06507059)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: SUPLA

StatusRecruiting

PhasePhase 3

SponsorChang Gung Memorial Hospital

Started2024-07-19

View on ClinicalTrials.gov ↗

Record status

This record was last updated August 23, 2024 (before its estimated July 1, 2025 completion). Its status may not reflect the trial's current state.

Amendment history

2024-08-21

Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1

Trial statusNot Yet Recruiting→Recruiting

Start dateestimated 2024-07-10→confirmed 2024-07-19

Study sitesdetails revised at 4 of 4 sites

2024-07-11

Original filing

Chang Gung Memorial Hospital

226 trials monitored

See 6 trials at risk

This study aims to determine whether people living with HIV (PLHIV) with suboptimal medical adherence can achieve better viral suppression with long-acting antiretrovirals (LA) compared to all-oral antiretrovirals.

Trial Details

NCT Number	NCT06507059
Lead Sponsor	Chang Gung Memorial Hospital Collaborators: Taoyuan General Hospital
Conditions	HIV-1-infection, Non-Adherence, Medication
Enrollment	40 participants
Start Date	2024-07-19
Primary Completion	2025-07-01 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2024-08-23